rs151344478

Variant summary

Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM1PM2PP3_Strong

The NM_000397.4(CYBB):​c.1601T>A​(p.Val534Asp) variant causes a missense change. The variant allele was found at a frequency of 0.000000913 in 1,095,817 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V534I) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 9.1e-7 ( 0 hom. 0 hem. )

Consequence

CYBB
NM_000397.4 missense

Scores

12
4
1

Clinical Significance

Uncertain significance no assertion criteria provided U:1O:1

Conservation

PhyloP100: 5.44

Publications

4 publications found
Variant links:
Genes affected
CYBB (HGNC:2578): (cytochrome b-245 beta chain) Cytochrome b (-245) is composed of cytochrome b alpha (CYBA) and beta (CYBB) chain. It has been proposed as a primary component of the microbicidal oxidase system of phagocytes. CYBB deficiency is one of five described biochemical defects associated with chronic granulomatous disease (CGD). In this disorder, there is decreased activity of phagocyte NADPH oxidase; neutrophils are able to phagocytize bacteria but cannot kill them in the phagocytic vacuoles. The cause of the killing defect is an inability to increase the cell's respiration and consequent failure to deliver activated oxygen into the phagocytic vacuole. [provided by RefSeq, Jul 2008]
CYBB Gene-Disease associations (from GenCC):
  • granulomatous disease, chronic, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • chronic granulomatous disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked Mendelian susceptibility to mycobacterial diseases due to CYBB deficiency
    Inheritance: XL, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 8 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_000397.4
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.995

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYBBNM_000397.4 linkc.1601T>A p.Val534Asp missense_variant Exon 13 of 13 ENST00000378588.5 NP_000388.2
CYBBXM_047441855.1 linkc.1295T>A p.Val432Asp missense_variant Exon 12 of 12 XP_047297811.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYBBENST00000378588.5 linkc.1601T>A p.Val534Asp missense_variant Exon 13 of 13 1 NM_000397.4 ENSP00000367851.4
ENSG00000250349ENST00000465127.1 linkc.171+384805T>A intron_variant Intron 3 of 8 5 ENSP00000417050.1

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
AF:
9.13e-7
AC:
1
AN:
1095817
Hom.:
0
Cov.:
29
AF XY:
0.00
AC XY:
0
AN XY:
361519
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26349
American (AMR)
AF:
0.00
AC:
0
AN:
35167
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19331
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54108
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40229
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4120
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
840355
Other (OTH)
AF:
0.00
AC:
0
AN:
45998
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
23

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Granulomatous disease, chronic, X-linked Uncertain:1
Oct 02, 2015
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Other:1
-
UniProtKB/Swiss-Prot
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.70
D
BayesDel_noAF
Pathogenic
0.77
CADD
Pathogenic
29
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.99
D
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.97
D
M_CAP
Pathogenic
0.95
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.8
H
PhyloP100
5.4
PrimateAI
Uncertain
0.64
T
PROVEAN
Pathogenic
-5.6
D
REVEL
Pathogenic
0.97
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.94
MutPred
0.94
Gain of disorder (P = 0.1446);
MVP
1.0
MPC
2.0
ClinPred
1.0
D
GERP RS
5.7
Varity_R
0.99
gMVP
1.0
Mutation Taster
=6/94
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151344478; hg19: chrX-37670058; API